Cartilage Repair Market Overview:
The Global Cartilage Repair Market was valued at $713 million in 2017, and is estimated to reach at $2,195 million by 2025, registering a CAGR of 15.0% from 2018 to 2025. The articular cartilage is a nonvascular connective tissue, which covers the ends of bones where they conjoin to form joints. The major function associated with cartilage includes provision of a lubricated and smooth surface for bone movement. Cartilage can be damaged due to injuries, timely wear & tear, and diseases such as osteoarthritis. The procedure undertaken to repair this damage is known as cartilage repair.
The global cartilage repair market is segmented based on modality, type, application, end user, and region. By modality, the market is divided into chondroplasty & microfracture, autologous chondrocyte implantation, osteochondral allograft, and juvenile allograft fragments. On the basis of type, it is bifurcated into hyaline cartilage and fibrocartilage. The applications covered in the study include knee, shoulder, and others. Depending on end user, the market is categorized into hospitals & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across the North America, Europe, Asia-Pacific, and LAMEA.
Osteochondral allograft dominated the cartilage repair market in 2017, owing to its versatility to treat large defects of the subchondral bone and generally successful outcomes associated with this modality.
Rise in focus of vendors on the emerging markets, such as Asia-Pacific and LAMEA, is expected to boost the market growth. Asia-Pacific is projected to witness significant growth in future, owing to increase in R&D investment and surge in osteoarthritis awareness. Furthermore, this region presents remarkable opportunities for the venture capitalists and investors, as the developed markets are comparatively saturated.
The report provides an extensive competitive analysis and profiles of the key market players such as Arthrex, Inc., B. Braun Melsungen AG, Conmed Corporation, Johnson & Johnson, Osiris Therapeutics, Inc., RTI Surgical, Inc., Smith & Nephew PLC, Stryker Corporation, Vericel Corporation, and Zimmer Biomet Holdings, Inc. The other players in the value chain (not included in the report) include Anika Therapeutics, Inc., Collagen Solutions LLP, and Histogenics Corporation.
- This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of global cartilage repair market.
- Market size and estimations are based on comprehensive analysis of the modalities, applications, end users, and developments in the industry.
- An in-depth analysis based on region assists to understand the regional market and facilitate the strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
Cartilage Repair Market Report Highlights
By END USER
Key Market Players
Zimmer Biomet Holdings, Inc, Conmed Corporation, RTI Surgical, Inc, Arthrex, Inc, Osiris Therapeutics, Inc, Vericel Corporation, Johnson & Johnson, B. Braun Melsungen AG, Smith & Nephew Plc, Stryker Corporation
Cartilage repair is executed through modalities such as chondroplasty & microfracture, autologous chondrocyte implantation, osteochondral allograft, and others to restore the damaged cartilage tissue. The demand for cartilage repair products has increased considerably, owing to increase in prevalence of degenerative diseases such as osteoarthritis in both developed and developing economies.
The growth of the cartilage repair market is propelled by upsurge in geriatric population, increase in prevalence of obesity, and rise of sedentary lifestyle in the populace. Furthermore, increase in awareness about cartilage repair products and surge in sports-related injuries are anticipated to boost the market growth in the forecast period.
The use of cartilage repair modalities is highest in North America, owing to availability of cartilage repair products, increased arthritis awareness, and rise in expenditure by the government on healthcare, followed by Europe and Asia-Pacific. In addition, orthopedic and medical device manufacturing companies have focused on expanding their presence in the emerging economies, which is anticipated to drive the market growth.